Apoptosis as a therapeutic paradigm in inflammatory bowel diseases

被引:0
|
作者
Verstege, Marleen I.
Velde, Anje A. te
Hommes, Daan W.
机构
[1] Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
来源
ACTA GASTRO-ENTEROLOGICA BELGICA | 2006年 / 69卷 / 04期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Evidence is increasing that a defect in apoptosis is involved in the pathogenesis of inflammatory bowel diseases (1131)), including Crohn's disease (CD) and ulcerative colitis (UC). CD seems to be the cause of an intrinsic defect in the apoptotic pathway of (autoreactive) T cells, resulting in excessive T cell responses. In UC, an increased rate of apoptosis of epithelial cells is observed. In this review we will describe apoptotic mechanisms and their association to IBD. In addition, we will review how specific therapeutic approaches interact at different levels with the apoptotic pathway.
引用
收藏
页码:406 / 412
页数:9
相关论文
共 50 条
  • [21] The innate immune system as a therapeutic target in inflammatory bowel diseases
    Cario, E.
    Podolsky, D. K.
    INTESTINAL DISORDERS, 2009, 164 : 71 - 76
  • [22] Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases
    Bonaz, Bruno
    Sinniger, Valerie
    Pellissier, Sonia
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [23] Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases?
    Keely, Stephen J.
    Steer, Clifford J.
    Lajczak-McGinley, Natalia K.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2019, 317 (06): : G872 - G881
  • [24] Recent advances in cytokines: Therapeutic implications for inflammatory bowel diseases
    Bouguen, Guillaume
    Chevaux, Jean-Baptiste
    Peyrin-Biroulet, Laurent
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (05) : 547 - 556
  • [25] Inflammatory bowel diseases: The paradigm for 21st century medicine - Introduction
    Sartor, RB
    Mayer, L
    GASTROENTEROLOGY, 2004, 126 (06) : 1503 - 1503
  • [26] Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications
    Mudter, J.
    Neurath, M. F.
    GUT, 2007, 56 (02) : 293 - 303
  • [27] Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases
    Mazur, Marzena
    Zielinska, Anna
    Grzybowski, Marcin M.
    Olczak, Jacek
    Fichna, Jakub
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [28] Special Issue "Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets"
    Filidou, Eirini
    Kolios, George
    PHARMACEUTICALS, 2023, 16 (05)
  • [29] THERAPEUTIC CUT-OFF OF INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Nagore, D.
    Ruiz del Agua, A.
    Pascual, J.
    Llinares-Tello, F.
    Herreros, B.
    Martinez, A.
    Martin, S.
    Navarro, R.
    GUT, 2015, 64 : A99 - A99
  • [30] RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
    Honjo, Hajime
    Watanabe, Tomohiro
    Kamata, Ken
    Minaga, Kosuke
    Kudo, Masatoshi
    FRONTIERS IN PHARMACOLOGY, 2021, 12